Contemporary Phytomedicines

個数:

Contemporary Phytomedicines

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 366 p.
  • 言語 ENG
  • 商品コード 9781498773553
  • DDC分類 615.321

Full Description

The term phytomedicine was coined by French physician Henri Leclerc in 1913. Till recently phytomedicine has remained in the background. But due to emerging challenges to the conventional pharmaceutical industry (cost effectiveness and potency of the drugs), phytomedicine has made a dramatic comeback. Phytomedicine has witnessed several changes and several new concepts have been introduced. Phytomedicine, although, a separate discipline, is strongly linked to Phytotherapy and Phytopharmacology.

As the title suggests the book is an attempt to bridge the gap between fundamental and emerging concepts in this field of medicine. The book has been divided into two parts.

Part A deals with core issues of the phyto-pharmaceutical drug industry. The book begins with an introductory chapter dealing with basic definitions with phytomedicine. Chapters 2-5 narrate emerging subjects such as Phytopharmacovigilance, Phytopharmacoeconomics, Phytopharmacoepidemiology and Phytopharmacogenomics. Chapter 6 discusses ethical issues in phytomedicine. Chapter 7 covers recent advances in drug delivery systems in phytomedicine whereas Chapter 8 is about application of nanotechnology in the field of phytomedicine. The further chapters cover metabolomics, regulatory and legal aspects of the phyto-pharmaceutical drug industry. The chapter on herbal bioavailability enhancing agents is the salient feature of Part-A.

Part B is related to applied research in the field of phytomedicine. Experimental findings on phyto-bioactive agents such as withanolides, steroidal alkaloids, phytosteroids and phytocannabinoids have been elaborated.

Nine annexures related to herbal drug registration are included.

Contents

Industrial Aspects of Phytomedicine. Introduction to Phytomedicine. Phytopharmacovigilance. Phytopharmacoeconomics. Phytopharmacoepidemiology. Phytopharmacogenomics. Ethics in Phytomedicine. Herbosomes. Nanophytomedicine. Metabolomics and Phytomedicine. Clinical Research in Ayurveda. Excepients for Phytomedicine. Certifications for Phytodrug Industry. Dhsea. Acts Related to Banned or Restricted Phyto Ingredients. Comfrey Based Herbal Products. Herbal Bioenhancers. Bioactives from Phytomedicine. Phytosteroids and Related Compounds. Botany Of Phytosteroids Containing Medicinal Plants. Pharmacology of Β-Sitosterol and Other Sterols. Pharmacology of Disogenin and Related Compounds. Steroidal Alkaloids. Guggulsterones. Phytoecdysteroids. Botany of Withanolides Containing Medicinal Plants. Pharmacology of Withaferin A. Pharmacology of Withanolide A. Pharmacology of Withanone. Pharmacology of Withanolide D. Miscellaneous Withanolides. Sitoindosides. Pyrrolizidine Alkaloids. Phytocannabinoids. Wild Cannabis. Annexures (1-9) Related to Herbal Drug Registration. Acronyms and Abbrevations. Definitions. Herbal Glossary.

最近チェックした商品